Xenetic Biosciences shareholders to own ~15% post-combination
The deal terms indicate Xenetic Biosciences shareholders will own about 15% of the combined company.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.